Turrini Giulia, Purgato Marianna, Cadorin Camilla, Bartucz Monica, Cristofalo Doriana, Gastaldon Chiara, Nosè Michela, Ostuzzi Giovanni, Papola Davide, Prina Eleonora, Tedeschi Federico, Witteveen Anke B, Sijbrandij Marit, Barbui Corrado
WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation, Department of Neuroscience, Biomedicine and Movement Sciences, Section of Psychiatry, University of Verona, Verona, Italy.
Department of Clinical Psychology and Psychotherapy, Babeș-Bolyai University, Cluj-Napoca, Romania.
Lancet Reg Health Eur. 2024 Nov 29;48:101152. doi: 10.1016/j.lanepe.2024.101152. eCollection 2025 Jan.
Migrant populations are at increased risk of developing mental health problems. We aimed to compare the efficacy and acceptability of psychosocial interventions in this population.
We conducted a systematic review and network meta-analysis (NMA). Cochrane Central Register of randomised trials (CENTRAL), MEDLINE, PTSDpubs, PsycINFO, PubMed, CINAHL, EMBASE, Web of Science, Scopus, and ClinicalTrials.gov were searched from database inception to October 7, 2024, to identify randomized clinical trials assessing the efficacy of psychosocial interventions for migrant populations in reducing symptoms of post-traumatic stress disorder (PTSD), depression or anxiety. Studies with second-generation migrants were excluded if they comprised over 20% of participants. Two independent researchers screened, reviewed, and extracted data. The primary outcomes were the severity of PTSD, depression, and anxiety symptoms at post-intervention. Secondary outcomes included acceptability. Standardised mean differences (SMDs) and risk ratios (RRs) were pooled using pairwise and NMA. PROSPERO: CRD42023418817.
Of the 103 studies with 19,230 participants included, 96 contributed to the meta-analyses for at least one outcome, with women representing 64% of the participants. Narrative Exposure Therapy (NET), counselling, Eye Movement Desensitization and Reprocessing (EMDR), and creative expressive interventions demonstrated greater efficacy than treatment as usual (TAU) in reducing PTSD symptoms, with SMDs [95% Confidence Intervals (CIs)] ranging from -0.69 [-1.14, -0.24] to -0.60 [-1.20, -0.01], albeit with low confidence in the evidence. For depressive symptoms, Integrative therapy emerged as the top intervention compared to TAU, with moderate confidence (SMD [95% CI] = -0.70 [-1.21, -0.20]). For anxiety symptoms, NET, Integrative therapy, and Problem Management Plus (PM+)/Step-by-Step (SbS) were more effective than TAU, with SMDs [95% CIs] ranging from -1.32 [-2.05, -0.59] to -0.35 [-0.65, -0.05]. Still, the confidence in the evidence was low. Overall, head-to-head comparisons yielded inconclusive results, and the acceptability analysis revealed variations across interventions. 16% of the studies (17 studies) were classified as "high risk" of bias, 68% (70) as having "some concerns", and 18% (19) as "low risk". We identified considerable heterogeneity (I of >70%).
The analysis revealed no clear differences in the efficacy of psychosocial interventions compared to TAU for reducing symptoms of PTSD, depression, and anxiety. While certain interventions showed potential benefits, confidence in these findings was generally low, limiting the ability to draw definitive conclusions about their comparative effectiveness.
This research received no specific grant from any funding agency.
移民人群出现心理健康问题的风险增加。我们旨在比较心理社会干预措施在该人群中的疗效和可接受性。
我们进行了一项系统评价和网状Meta分析(NMA)。从数据库建立至2024年10月7日,检索了Cochrane随机对照试验中心注册库(CENTRAL)、MEDLINE、PTSDpubs、PsycINFO、PubMed、CINAHL、EMBASE、Web of Science、Scopus和ClinicalTrials.gov,以识别评估心理社会干预措施对移民人群减轻创伤后应激障碍(PTSD)、抑郁或焦虑症状疗效的随机临床试验。如果第二代移民在参与者中占比超过20%,则排除相关研究。两名独立研究人员进行筛选、评审并提取数据。主要结局为干预后PTSD、抑郁和焦虑症状的严重程度。次要结局包括可接受性。使用成对分析和NMA汇总标准化均数差(SMD)和风险比(RR)。国际前瞻性系统评价注册库(PROSPERO)注册号:CRD42023418817。
纳入的103项研究共19230名参与者中,96项研究至少对一项结局进行了Meta分析,其中女性占参与者的64%。叙事暴露疗法(NET)、咨询、眼动脱敏再处理疗法(EMDR)和创造性表达干预措施在减轻PTSD症状方面比常规治疗(TAU)更有效,SMD [95%置信区间(CI)]为-0.69 [-1.14, -0.24]至-0.60 [-1.20, -0.01],尽管证据的可信度较低。对于抑郁症状,与TAU相比,综合疗法是最有效的干预措施,可信度中等(SMD [95% CI] = -0.70 [-1.21, -0.20])。对于焦虑症状,NET、综合疗法和问题管理强化版(PM+)/逐步治疗法(SbS)比TAU更有效,SMD [95% CI]为-1.32 [-2.05, -0.59]至-0.35 [-0.65, -0.05]。不过,证据的可信度较低。总体而言,直接比较的结果尚无定论,可接受性分析显示不同干预措施存在差异。16%的研究(17项研究)被归类为“高风险”偏倚,68%(70项)存在“一些担忧”,18%(19项)为“低风险”。我们发现存在相当大的异质性(I²>70%)。
分析显示,与TAU相比,心理社会干预措施在减轻PTSD、抑郁和焦虑症状方面的疗效没有明显差异。虽然某些干预措施显示出潜在益处,但对这些结果的信心普遍较低,限制了就其相对有效性得出明确结论的能力。
本研究未获得任何资助机构的特定资助。